Clinical Trials Directory

Trials / Sponsors / Cerus Corporation

Cerus Corporation

Industry · 17 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingComparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatme
Hypofibrinogenemia, Hemorrhage
—2026-05-01
Not Yet RecruitingChallenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-exi
Transfusion Reaction, Hemolytic
Phase 22026-01-01
WithdrawnBiotin-Acridine Red Cell Exchange Kinetics
Sickle Cell Disease
Phase 22025-10-15
RecruitingA Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RB
Healthy Subjects
Phase 22025-09-19
CompletedA Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCE
Healthy Subjects
Phase 22025-01-23
CompletedIn Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Comp
Healthy
Phase 22019-11-05
CompletedStudy to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Pati
Anemia
Phase 32018-12-05
Active Not RecruitingINTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infe
Anemia
Phase 32017-05-11
CompletedA Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
Transfusion Related Acute Lung Injury
—2015-12-01
TerminatedA Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study
Healthy
Phase 22015-12-01
CompletedA Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet C
Chikungunya Virus, Dengue Virus
—2015-03-01
CompletedA Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Tr
Healthy
Phase 22014-12-01
TerminatedA Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Usi
Acute Ebola Virus Disease
Phase 12014-12-01
CompletedStudy to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute
Focus:Use of S303 RBCs in Patients With Acute Anemia
Phase 32013-04-01
CompletedStudy to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major
Thalassemia Major
Phase 32012-12-01
CompletedA Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells
Focus: Assess Post Infusion Viability of S303 RBCs
Phase 22012-10-01
CompletedEfficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
Thrombocytopenia
Phase 32005-10-01